|
AU2004315596B2
(en)
*
|
2003-08-29 |
2011-11-24 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis
|
|
SE0302573D0
(sv)
|
2003-09-26 |
2003-09-26 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
DE10354060A1
(de)
*
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
|
US20100222316A1
(en)
|
2004-04-29 |
2010-09-02 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US8415354B2
(en)
|
2004-04-29 |
2013-04-09 |
Abbott Laboratories |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
PT1773768T
(pt)
*
|
2004-07-30 |
2018-11-30 |
Exelixis Inc |
Derivados de pirrol como agentes farmacêuticos
|
|
BRPI0515897A
(pt)
|
2004-09-24 |
2008-08-12 |
Astrazeneca Ab |
composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto
|
|
US8198331B2
(en)
|
2005-01-05 |
2012-06-12 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
CA2594116A1
(en)
|
2005-01-05 |
2006-07-13 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
KR101496190B1
(ko)
|
2005-01-05 |
2015-02-26 |
애브비 인코포레이티드 |
11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제로서의 아다만틸 유도체
|
|
US20090192198A1
(en)
|
2005-01-05 |
2009-07-30 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
JP5123668B2
(ja)
*
|
2005-01-10 |
2013-01-23 |
エグゼリクシス， インコーポレイテッド |
医薬品としての複素環カルボキサミド化合物
|
|
TW200745049A
(en)
|
2006-03-23 |
2007-12-16 |
Astrazeneca Ab |
New crystalline forms
|
|
TW200808769A
(en)
|
2006-04-18 |
2008-02-16 |
Astrazeneca Ab |
Therapeutic compounds
|
|
ES2375877T3
(es)
|
2006-10-31 |
2012-03-07 |
Pfizer Products Inc. |
Compuestos de pirazolina como antagonistas de receptores de mineralocorticoides.
|
|
TWI444185B
(zh)
|
2007-04-09 |
2014-07-11 |
Daiichi Sankyo Co Ltd |
吡咯衍生物之阻轉異構物
|
|
CA2696349A1
(en)
|
2007-08-15 |
2009-02-19 |
President And Fellows Of Harvard College |
Heterocyclic inhibitors of necroptosis
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
JP2010536871A
(ja)
*
|
2007-08-22 |
2010-12-02 |
アラーガン、インコーポレイテッド |
スフィンゴシン−１−リン酸受容体アゴニストまたはアンタゴニスト生物学的活性を有するピロール化合物
|
|
RU2465272C2
(ru)
|
2007-09-10 |
2012-10-27 |
КалсиМедика, Инк. |
Соединения, моделирующие внутриклеточный кальций
|
|
WO2009076454A2
(en)
*
|
2007-12-12 |
2009-06-18 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
CA2720164A1
(en)
*
|
2008-03-31 |
2009-10-08 |
Teva Pharmaceutical Industries Ltd. |
Processes for preparing sunitinib and salts thereof
|
|
GB0808282D0
(en)
*
|
2008-05-07 |
2008-06-11 |
Medical Res Council |
Compounds for use in stabilizing p53 mutants
|
|
LT2318006T
(lt)
|
2008-08-15 |
2017-01-10 |
Nivalis Therapeutics, Inc. |
Nauji s-nitrozoglutationo reduktazės pirolo inhibitoriai, kaip terapiniai agentai
|
|
US8642628B2
(en)
|
2008-08-15 |
2014-02-04 |
N30 Pharmaceuticals, Inc. |
Pyrrole inhibitors of S-nitrosoglutathione reductase
|
|
DK2318007T3
(da)
|
2008-08-15 |
2013-03-25 |
N30 Pharmaceuticals Inc |
Nye pyrrol-inhibitorer af s-nitrosoglutathion-reduktase som terapeutiske midler
|
|
CA2734500A1
(en)
*
|
2008-08-27 |
2010-03-11 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
US8524763B2
(en)
|
2008-09-22 |
2013-09-03 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
|
AU2009302371B2
(en)
|
2008-10-08 |
2015-02-12 |
Exelixis, Inc. |
Atropisomers of (hydroxyalkyl) pyrrole derivatives
|
|
CN102177137B
(zh)
*
|
2008-10-08 |
2015-03-18 |
埃克塞利希斯股份有限公司 |
1-苯基吡咯化合物
|
|
WO2010075561A1
(en)
|
2008-12-23 |
2010-07-01 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necroptosis
|
|
WO2010107476A1
(en)
*
|
2009-03-19 |
2010-09-23 |
Duke University |
Inhibiting gsnor
|
|
US8513289B2
(en)
*
|
2009-05-05 |
2013-08-20 |
Merck Sharp & Dohme Corp. |
P38 kinase inhibiting agents
|
|
EP2253617A1
(de)
*
|
2009-05-20 |
2010-11-24 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
EP2470183B1
(en)
*
|
2009-08-26 |
2015-09-16 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
US8618307B2
(en)
*
|
2009-09-16 |
2013-12-31 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
UY33200A
(es)
*
|
2010-01-26 |
2011-08-31 |
Sanofi Aventis |
Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos
|
|
EP2568986B1
(en)
|
2010-05-10 |
2016-01-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
|
|
EP2582365B1
(en)
|
2010-06-16 |
2019-03-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions for stimulating reepithelialisation during wound healing
|
|
CN103180316A
(zh)
|
2010-08-27 |
2013-06-26 |
钙医学公司 |
调节细胞内钙的化合物
|
|
WO2012061926A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Zalicus Pharmaceuticals Ltd. |
Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
|
|
EP2800745B1
(en)
|
2011-12-02 |
2020-02-12 |
Phenex Pharmaceuticals AG |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
EP2794565B1
(en)
|
2011-12-21 |
2017-07-26 |
Novira Therapeutics Inc. |
Hepatitis b antiviral agents
|
|
CA2881057C
(en)
|
2012-08-28 |
2020-10-27 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP6466348B2
(ja)
|
2013-02-28 |
2019-02-06 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用
|
|
WO2014145022A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Hybrid necroptosis inhibitors
|
|
HUE033542T2
(en)
|
2013-04-03 |
2017-12-28 |
Janssen Sciences Ireland Uc |
Their use as medicaments for the treatment of N-phenylcarboxamide derivatives and hepatitis B
|
|
KR102234597B1
(ko)
|
2013-04-10 |
2021-03-31 |
다이이찌 산쿄 가부시키가이샤 |
피롤 유도체의 결정 및 그 제조 방법
|
|
TW202126620A
(zh)
|
2013-05-17 |
2021-07-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
胺磺醯基吡咯醯胺衍生物及其作為用於治療ｂ型肝炎藥物的用途
|
|
HUE040446T2
(hu)
|
2013-05-17 |
2019-03-28 |
Janssen Sciences Ireland Uc |
Szulfamoiltiofenamid-származékok és gyógyszerként történõ alkalmazásuk hepatitis B kezelésére
|
|
JP6422868B2
(ja)
|
2013-07-23 |
2018-11-14 |
第一三共株式会社 |
高血圧症の予防又は治療のための医薬
|
|
WO2015011281A1
(en)
|
2013-07-25 |
2015-01-29 |
Janssen R&D Ireland |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
|
HUE037007T2
(hu)
|
2013-08-27 |
2018-08-28 |
Daiichi Sankyo Co Ltd |
Eljárás pirrol származék elõállítására és annak intermediere
|
|
MX368158B
(es)
|
2013-10-23 |
2019-09-20 |
Janssen Sciences Ireland Uc |
Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
|
|
WO2015083130A1
(en)
*
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
|
US10392349B2
(en)
|
2014-01-16 |
2019-08-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
JP6553059B2
(ja)
|
2014-02-05 |
2019-07-31 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
Ｈｂｖ感染の治療のための併用療法
|
|
PL3102572T3
(pl)
|
2014-02-06 |
2019-04-30 |
Janssen Sciences Ireland Uc |
Pochodne sulfamoilopirolamidu i ich zastosowanie jako leki do leczenia wirusowego zapalenia wątroby typu B
|
|
WO2016094846A1
(en)
|
2014-12-11 |
2016-06-16 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis and related methods
|
|
CA2973944C
(en)
*
|
2015-01-26 |
2019-07-30 |
Daiichi Sankyo Company, Limited |
Solid composition of pyrrole carboxamide
|
|
EP3286172B1
(en)
|
2015-04-23 |
2019-06-12 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
|
TWI623316B
(zh)
*
|
2015-12-22 |
2018-05-11 |
Taiho Pharmaceutical Co Ltd |
Antitumor effect enhancer derived from pyrrolopyrimidine compound
|
|
WO2017151786A1
(en)
|
2016-03-01 |
2017-09-08 |
University Of Maryland, Baltimore |
Wnt signaling pathway inhibitors for treatments of disease
|
|
EP3434284A4
(en)
|
2016-03-24 |
2019-11-13 |
Daiichi Sankyo Company, Limited |
MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
|
|
WO2017181141A2
(en)
|
2016-04-15 |
2017-10-19 |
Novira Therapeutics, Inc. |
Combinations and methods comprising a capsid assembly inhibitor
|
|
US11331308B2
(en)
|
2016-10-11 |
2022-05-17 |
Bayer Pharma Aktiengesellschaft |
Combination containing sGC activators and mineralocorticoid receptor antagonists
|
|
ES2985316T3
(es)
|
2016-10-11 |
2024-11-05 |
Bayer Pharma AG |
Combinación que contiene el estimulador sGC vericuguat y el antagonista de los receptores de corticoides minerales finerenona
|
|
LT3532459T
(lt)
|
2016-10-26 |
2023-11-10 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitoriai ir jų medicininis panaudojimas
|
|
WO2018153898A1
(de)
|
2017-02-22 |
2018-08-30 |
Bayer Pharma Aktiengesellschaft |
Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit mineralocorticoid-rezeptor-antagonisten
|
|
DE102017008472A1
(de)
|
2017-09-08 |
2018-05-03 |
Bayer Pharma Aktiengesellschaft |
Kombination enthaltend PDE5 Inhibitoren und Mineralocorticoid-Rezeptor-Antagonisten
|
|
SG11202007097QA
(en)
|
2018-03-14 |
2020-08-28 |
Janssen Sciences Ireland Unlimited Co |
Capsid assembly modulator dosing regimen
|
|
WO2019185016A1
(zh)
|
2018-03-30 |
2019-10-03 |
正大天晴药业集团股份有限公司 |
含有n杂五元环的衣壳蛋白装配抑制剂、其药物组合物和用途
|
|
EA202092159A1
(ru)
|
2019-01-25 |
2020-12-15 |
Чиа Тай Тянцин Фармасьютикал Груп Ко., Лтд. |
Содержащий n-гетероциклическое пятичленное кольцо ингибитор сборки капсидного белка, его фармацевтическая композиция и их применение
|
|
AU2020223865A1
(en)
|
2019-02-22 |
2021-07-15 |
Janssen Sciences Ireland Unlimited Company |
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
|
|
BR112021021454A2
(pt)
|
2019-05-06 |
2021-12-21 |
Janssen Sciences Ireland Unlimited Co |
Derivados de amida úteis no tratamento da infecção por hbv ou doenças induzidas por hbv
|
|
US12378192B2
(en)
|
2019-09-29 |
2025-08-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Crystalline form of capsid protein assembly inhibitor containing N hetero five-membered ring, and application thereof
|
|
WO2021058001A1
(zh)
|
2019-09-29 |
2021-04-01 |
正大天晴药业集团股份有限公司 |
N杂五元环化合物的晶型及其应用
|
|
AU2020371836B2
(en)
|
2019-10-25 |
2026-01-29 |
Sunshine Lake Pharma Co., Ltd. |
Pyrrole amide compound and use thereof
|
|
RU2738405C1
(ru)
*
|
2020-05-26 |
2020-12-11 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" |
АМИД (Е)-2-АМИНО-4-ОКСО-5-(2-ОКСО-2-ФЕНИЛЭТИЛИДЕН)-1-(3-ЭТОКСИКАРБОНИЛ)-4,5,6-7-ТЕТРАГИДРОБЕНЗО[b]ТИОФЕН-2-ИЛ)4,5-ДИГИДРО-1Н-ПИРРОЛ-3-КАРБОНОВОЙ КИСЛОТЫ, ОБЛАДАЮЩИЙ ПРОТИВОМИКРОБНОЙ АКТИВНОСТЬЮ
|
|
CA3179059A1
(en)
*
|
2020-06-09 |
2021-12-16 |
Anima Biotech Inc. |
Collagen 1 translation inhibitors and methods of use thereof
|
|
US20240239746A1
(en)
|
2021-04-26 |
2024-07-18 |
Sunshine Lake Pharma Co., Ltd. |
Preparation method for pyrrole amide compound
|
|
CN114456098B
(zh)
*
|
2022-01-19 |
2024-06-14 |
大连理工大学 |
糖尿病肾病药物艾莎利酮的制备方法
|